coronavirus treatment

Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.

Philanthropies are funding studies of cheap, existing meds like fluvoxamine as treatments. But early hype about hydroxychloroquine and other drugs leaves researchers leery of hasty conclusions.

Regeneron says tests in more than 4,000 recently diagnosed patients found its two-antibody combo drug cut the risk of hospitalization or death by 70%.

Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.

Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.

Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.

Speaking in a video released Wednesday morning, Gov. Ron DeSantis announced plans for the distribution of possible COVID-19 vaccines.

The drug is a combo of two antibodies to enhance the chances it will prove effective. It's an experimental medicine that President Trump was given when he was sickened last month.

NPR's Rachel Martin talks to Dr. Anthony Fauci, the country's top infectious disease expert, about promising results for vaccine candidates and his advice for staying safe during the holidays.

Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.